✦ LIBER ✦

471 ON-TREATMENT SERUM HEPATITIS B SURFACE ANTIGEN LEVEL PREDICTS SUSTAINED VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE IN PATIENTS WITH HEPATITIS E ANTIGEN-POSITIVE CHRONIC HEPATITIS B

✍ Scribed by S.S. Kim; J.Y. Cheong; D. Lee; M.H. Lee; S.W. Cho

Book ID: 117380683
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(12)60484-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of on-treatment serum hepati

Association of on-treatment serum hepatitis B surface antigen level with sustained virological response to nucleos(t)ide analog in patients with hepatitis B e-antigen positive chronic hepatitis B

✍ Soon Sun Kim; Dami Lee; Myoung Hee Lee; Jae Youn Cheong; Sung Won Cho 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 838 KB

Potent hepatitis B surface antigen respo

Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog

✍ Xinyue Chen; Zhenhuan Cao; Yali Liu; Hongwei Zhang; Yonghong Zhang; Lina Ma; Yi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 764 KB

486 QUANTIFICATION OF HEPATITIS B SURFAC

486 QUANTIFICATION OF HEPATITIS B SURFACE ANTIGEN AS A PREDICTOR OF OFF-TREATMENT SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ORAL NUCLEOS(T)IDE ANALOGUE

✍ S.J. Suh; J.E. Yeon; E.L. Yoon; H.J. Lee; S.J. Lee; S.H. Kang; K. Kang; J.H. Kim 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Prediction of sustained response to pegi

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen–positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

✍ Milan J. Sonneveld; Vincent Rijckborst; Charles A. B. Boucher; Bettina E. Hansen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB 👁 1 views

Serum hepatitis B surface antigen (HBsAg) levels may reflect the immunomodulatory efficacy of pegylated interferon (PEG-IFN). We investigated within a large randomized trial whether quantitative HBsAg levels predict response to PEG-IFN in patients with hepatitis B e antigen (HBeAg)-positive chronic

Comparison between quantitative hepatiti

Comparison between quantitative hepatitis B surface antigen, hepatitis B e-antigen and hepatitis B virus DNA levels for predicting virological response to pegylated interferon-α-2b therapy in hepatitis B e-antigen-positive chronic hepatitis B

✍ Pisit Tangkijvanich; Piyawat Komolmit; Varocha Mahachai; Pattaratida Sa-nguanmoo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB

Correlation of serum hepatitis B surface

Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B

✍ Myoung Hee Lee; Da Mi Lee; Soon Sun Kim; Jae Youn Cheong; Sung Won Cho 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 2 views

## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAg‐positive and HBeAg